Stephen Tseng
Internal Medicine · Bryan, TXNPI 1952311326
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.1% of the total across 384 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 22.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,297 and has fallen 88.7% since, to $258 in 2022. Among internal medicine clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 384 payments — averaging $15.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- Pfizer$534
- Lilly USA, LLC$497
- AbbVie$426
- AstraZeneca$396
- Astellas Pharma US Inc$388
- plus $2K from 30 others
What the payments were for
- Food & beverage$5,75096%
- Education$2344%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 86 | $1,322 |
| Pfizer | 49 | $534 |
| Lilly USA, LLC | 29 | $497 |
| AbbVie(2 entities) | 31 | $426 |
| AstraZeneca | 24 | $396 |
| Astellas Pharma US Inc | 16 | $388 |
| Johnson & Johnson | 14 | $311 |
| Boehringer Ingelheim | 19 | $265 |
| Amgen | 16 | $240 |
| Amarin Pharma, Inc. | 13 | $223 |
| Sanofi-aventis U.S. LLC | 14 | $197 |
| Merck | 12 | $153 |
| Kowa Pharmaceuticals America, Inc. | 8 | $116 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $95 |
| E.r. Squibb & Sons, L.L.C. | 5 | $87 |
| Sunovion Pharmaceuticals Inc. | 4 | $79 |
| Hikma Pharmaceuticals USA | 5 | $76 |
| Abbott | 3 | $58 |
| Esperion Therapeutics, Inc. | 3 | $57 |
| Itamar Medical Inc | 1 | $56 |
| Genentech USA, Inc. | 3 | $53 |
| GSK | 4 | $53 |
| Novartis | 3 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
| Medtronic(2 entities) | 2 | $27 |
| Philips North America LLC | 2 | $26 |
| Bayer | 1 | $23 |
| Eyevance Pharmaceuticals LLC | 1 | $21 |
| Biogen | 1 | $19 |
| Antares Pharma, Inc. | 1 | $18 |
| Dexcom, Inc. | 1 | $17 |
| IBSA Pharma Inc. | 1 | $17 |
| Eisai Inc. | 1 | $16 |
| Acerus Pharmaceuticals Corporation | 1 | $15 |
| Seqirus USA Inc | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XARELTO$120
How this compares
$5,984 in reported general payments places this provider in the 90th percentile of 7,675 internal medicine providers in Texas.
Other internal medicine in Bryan
- Spencer BerthelsenSugar Land$891K
- Hameed AliTemple$773K
- Marc TribbleDallas$693K
- Gary SinclairDallas$599K
- Mohammed Al-NajjarEl Paso$586K
- Han SchmidlyDallas$465K
- Hussein TawbiHouston$365K
- Hans LeeHouston$327K
- Tapan KadiaHouston$311K
- Nitin JainHouston$281K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.